Avash Das, M.B.,B.S., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Vascular Endothelial Growth Factor | 2 | 2020 | 666 | 0.700 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2024 | 1135 | 0.620 |
Why?
|
Pyelitis | 1 | 2016 | 1 | 0.560 |
Why?
|
Orbital Cellulitis | 1 | 2017 | 33 | 0.560 |
Why?
|
Population Growth | 1 | 2016 | 50 | 0.540 |
Why?
|
Pyelonephritis | 1 | 2016 | 75 | 0.540 |
Why?
|
Ethylene Glycol | 1 | 2016 | 31 | 0.540 |
Why?
|
Hypolipidemic Agents | 2 | 2023 | 626 | 0.540 |
Why?
|
Foot Dermatoses | 1 | 2016 | 47 | 0.530 |
Why?
|
Brugada Syndrome | 1 | 2016 | 95 | 0.510 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2017 | 169 | 0.490 |
Why?
|
Hematuria | 1 | 2016 | 233 | 0.480 |
Why?
|
Acidosis | 1 | 2016 | 268 | 0.460 |
Why?
|
Hepatitis, Viral, Human | 1 | 2014 | 141 | 0.460 |
Why?
|
Confusion | 1 | 2016 | 279 | 0.450 |
Why?
|
Emphysema | 1 | 2016 | 240 | 0.450 |
Why?
|
Dyslipidemias | 2 | 2023 | 895 | 0.440 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2024 | 2895 | 0.430 |
Why?
|
Sarcoma, Kaposi | 1 | 2016 | 376 | 0.420 |
Why?
|
Cardiovascular Diseases | 6 | 2023 | 15757 | 0.420 |
Why?
|
Fluoxetine | 1 | 2016 | 733 | 0.420 |
Why?
|
Embolism | 1 | 2016 | 408 | 0.410 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2016 | 662 | 0.410 |
Why?
|
Endocarditis, Bacterial | 1 | 2016 | 445 | 0.400 |
Why?
|
Cytomegalovirus | 1 | 2014 | 755 | 0.350 |
Why?
|
Membrane Proteins | 2 | 2024 | 7850 | 0.340 |
Why?
|
Immunocompromised Host | 1 | 2014 | 857 | 0.330 |
Why?
|
Lipids | 1 | 2020 | 3336 | 0.320 |
Why?
|
Dyspnea | 1 | 2016 | 1352 | 0.300 |
Why?
|
Cytomegalovirus Infections | 1 | 2014 | 831 | 0.300 |
Why?
|
DNA, Viral | 1 | 2014 | 2194 | 0.290 |
Why?
|
Protein Kinase Inhibitors | 2 | 2020 | 5643 | 0.280 |
Why?
|
Staphylococcal Infections | 1 | 2016 | 1407 | 0.280 |
Why?
|
Phospholipases A2, Calcium-Independent | 1 | 2024 | 11 | 0.230 |
Why?
|
Antidepressive Agents | 1 | 2016 | 2890 | 0.230 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2016 | 3602 | 0.230 |
Why?
|
Hemorrhage | 1 | 2016 | 3600 | 0.230 |
Why?
|
Multiple Myeloma | 1 | 2021 | 5130 | 0.220 |
Why?
|
Lipoproteins, VLDL | 1 | 2024 | 201 | 0.210 |
Why?
|
Neutropenia | 2 | 2019 | 884 | 0.210 |
Why?
|
Heart Failure | 4 | 2021 | 11847 | 0.210 |
Why?
|
Depression | 2 | 2020 | 8044 | 0.200 |
Why?
|
Acyltransferases | 1 | 2024 | 305 | 0.200 |
Why?
|
RNA, Nuclear | 1 | 2021 | 30 | 0.200 |
Why?
|
Ubiquitin | 2 | 2024 | 838 | 0.190 |
Why?
|
Diagnosis, Differential | 5 | 2016 | 12965 | 0.190 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2020 | 748 | 0.160 |
Why?
|
Depressive Disorder, Major | 1 | 2016 | 4744 | 0.160 |
Why?
|
Blood Cells | 1 | 2020 | 305 | 0.150 |
Why?
|
Humans | 40 | 2024 | 760621 | 0.140 |
Why?
|
Hepatocytes | 1 | 2024 | 1229 | 0.140 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2021 | 10344 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20509 | 0.140 |
Why?
|
Skin Neoplasms | 1 | 2016 | 5799 | 0.140 |
Why?
|
Heel | 1 | 2016 | 37 | 0.130 |
Why?
|
Transplantation, Heterotopic | 1 | 2016 | 174 | 0.130 |
Why?
|
Cholecystitis | 1 | 2016 | 181 | 0.130 |
Why?
|
Arsenic Poisoning | 1 | 2016 | 55 | 0.130 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2021 | 396 | 0.130 |
Why?
|
Lipid Metabolism | 2 | 2021 | 1902 | 0.130 |
Why?
|
Nephrostomy, Percutaneous | 1 | 2016 | 82 | 0.130 |
Why?
|
Pigmentation | 1 | 2016 | 144 | 0.130 |
Why?
|
Hypertension, Pulmonary | 2 | 2016 | 1570 | 0.130 |
Why?
|
Patients' Rooms | 1 | 2015 | 62 | 0.130 |
Why?
|
Stomach Ulcer | 1 | 2015 | 123 | 0.130 |
Why?
|
Acid-Base Equilibrium | 1 | 2016 | 180 | 0.130 |
Why?
|
Addison Disease | 1 | 2015 | 48 | 0.130 |
Why?
|
Antidotes | 1 | 2016 | 138 | 0.130 |
Why?
|
Gene Library | 1 | 2018 | 1060 | 0.120 |
Why?
|
RNA, Transfer | 1 | 2017 | 289 | 0.120 |
Why?
|
Acetamides | 1 | 2016 | 256 | 0.120 |
Why?
|
Prolactinoma | 1 | 2015 | 113 | 0.120 |
Why?
|
Urine | 1 | 2016 | 363 | 0.120 |
Why?
|
Asia | 1 | 2016 | 620 | 0.120 |
Why?
|
Hernia, Diaphragmatic | 1 | 2015 | 246 | 0.120 |
Why?
|
Fish Oils | 1 | 2018 | 482 | 0.120 |
Why?
|
Physical Exertion | 1 | 2017 | 662 | 0.120 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2024 | 1889 | 0.120 |
Why?
|
Grief | 1 | 2016 | 254 | 0.120 |
Why?
|
Prescriptions | 1 | 2016 | 388 | 0.110 |
Why?
|
Hyponatremia | 1 | 2016 | 279 | 0.110 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2016 | 141 | 0.110 |
Why?
|
Polypharmacy | 1 | 2016 | 307 | 0.110 |
Why?
|
Adenine | 1 | 2019 | 975 | 0.110 |
Why?
|
Urinalysis | 1 | 2016 | 368 | 0.110 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2017 | 479 | 0.110 |
Why?
|
Treatment Refusal | 1 | 2017 | 430 | 0.110 |
Why?
|
Ureter | 1 | 2016 | 375 | 0.110 |
Why?
|
Myocardial Infarction | 3 | 2021 | 11891 | 0.110 |
Why?
|
Drug Therapy | 1 | 2016 | 504 | 0.110 |
Why?
|
Physical Conditioning, Animal | 1 | 2017 | 366 | 0.110 |
Why?
|
Emigration and Immigration | 1 | 2016 | 395 | 0.110 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2019 | 708 | 0.110 |
Why?
|
Lymphoma, B-Cell | 1 | 2019 | 935 | 0.110 |
Why?
|
Cardiovascular Agents | 1 | 2019 | 867 | 0.100 |
Why?
|
Arsenic | 1 | 2016 | 357 | 0.100 |
Why?
|
Erythrocytes | 1 | 2021 | 2415 | 0.100 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2016 | 368 | 0.100 |
Why?
|
Infection Control | 1 | 2019 | 983 | 0.100 |
Why?
|
Metformin | 1 | 2019 | 912 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 3 | 2018 | 36290 | 0.090 |
Why?
|
Piperidines | 1 | 2019 | 1650 | 0.090 |
Why?
|
Fibrosis | 1 | 2018 | 2042 | 0.090 |
Why?
|
Pyrazines | 1 | 2016 | 1199 | 0.090 |
Why?
|
Middle Aged | 13 | 2020 | 220352 | 0.090 |
Why?
|
Hospitals, Teaching | 1 | 2015 | 1166 | 0.090 |
Why?
|
Angiogenesis Inhibitors | 1 | 2020 | 2049 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2380 | 0.090 |
Why?
|
Male | 19 | 2021 | 359744 | 0.090 |
Why?
|
Urinary Bladder | 1 | 2016 | 1166 | 0.090 |
Why?
|
Intubation, Intratracheal | 1 | 2018 | 1328 | 0.090 |
Why?
|
Emigrants and Immigrants | 1 | 2016 | 539 | 0.090 |
Why?
|
HIV Infections | 1 | 2016 | 17165 | 0.080 |
Why?
|
Anemia | 2 | 2016 | 1511 | 0.080 |
Why?
|
Animals | 10 | 2024 | 167963 | 0.080 |
Why?
|
Fever | 1 | 2016 | 1617 | 0.080 |
Why?
|
Inflammation | 2 | 2020 | 10756 | 0.080 |
Why?
|
Risk Factors | 5 | 2020 | 74359 | 0.080 |
Why?
|
Myocardium | 1 | 2021 | 4700 | 0.080 |
Why?
|
Mice | 4 | 2024 | 81208 | 0.080 |
Why?
|
Dexamethasone | 1 | 2015 | 1927 | 0.080 |
Why?
|
Patient Preference | 1 | 2015 | 922 | 0.080 |
Why?
|
RNA | 1 | 2018 | 2722 | 0.080 |
Why?
|
Atherosclerosis | 1 | 2024 | 3517 | 0.070 |
Why?
|
Headache | 1 | 2015 | 1249 | 0.070 |
Why?
|
Female | 15 | 2021 | 391270 | 0.070 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 16939 | 0.070 |
Why?
|
Pituitary Neoplasms | 1 | 2015 | 1313 | 0.070 |
Why?
|
Respiration, Artificial | 1 | 2018 | 2622 | 0.070 |
Why?
|
Renal Dialysis | 1 | 2016 | 1801 | 0.070 |
Why?
|
Hypoglycemic Agents | 1 | 2019 | 3150 | 0.070 |
Why?
|
Myocytes, Cardiac | 3 | 2021 | 1657 | 0.070 |
Why?
|
Sex Factors | 1 | 2020 | 10547 | 0.070 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2018 | 2299 | 0.060 |
Why?
|
Pyrazoles | 1 | 2016 | 1999 | 0.060 |
Why?
|
Patient Readmission | 1 | 2020 | 3323 | 0.060 |
Why?
|
Neoplasms | 3 | 2019 | 22072 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6068 | 0.060 |
Why?
|
Obesity | 2 | 2018 | 12922 | 0.060 |
Why?
|
Adult | 10 | 2020 | 219994 | 0.060 |
Why?
|
Health Status Disparities | 1 | 2016 | 1830 | 0.060 |
Why?
|
Blood Glucose | 1 | 2019 | 6381 | 0.060 |
Why?
|
Escherichia coli | 1 | 2016 | 4219 | 0.060 |
Why?
|
Electrocardiography | 1 | 2016 | 6414 | 0.050 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3758 | 0.050 |
Why?
|
Brain | 3 | 2020 | 26951 | 0.050 |
Why?
|
Palliative Care | 1 | 2018 | 3607 | 0.050 |
Why?
|
Heart Transplantation | 1 | 2016 | 3224 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2018 | 4319 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
Skin | 1 | 2016 | 4466 | 0.050 |
Why?
|
Physician-Patient Relations | 1 | 2015 | 3242 | 0.050 |
Why?
|
Aged | 6 | 2020 | 169152 | 0.050 |
Why?
|
Signal Transduction | 2 | 2021 | 23376 | 0.050 |
Why?
|
Receptors, LDL | 1 | 2024 | 488 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2023 | 65017 | 0.050 |
Why?
|
Exercise | 1 | 2017 | 5787 | 0.050 |
Why?
|
Diet | 1 | 2019 | 8010 | 0.050 |
Why?
|
Kidney | 1 | 2016 | 7064 | 0.050 |
Why?
|
Lipoproteins, LDL | 1 | 2024 | 641 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5889 | 0.040 |
Why?
|
Monocrotaline | 1 | 2020 | 27 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8624 | 0.040 |
Why?
|
Oligonucleotides, Antisense | 1 | 2023 | 459 | 0.040 |
Why?
|
Kainic Acid | 1 | 2020 | 199 | 0.040 |
Why?
|
Discriminant Analysis | 1 | 2020 | 223 | 0.040 |
Why?
|
Exercise Test | 2 | 2017 | 2128 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2023 | 17790 | 0.040 |
Why?
|
Prevalence | 1 | 2016 | 15687 | 0.040 |
Why?
|
Risk Assessment | 2 | 2020 | 24123 | 0.040 |
Why?
|
Phenotype | 1 | 2016 | 16546 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2021 | 9530 | 0.040 |
Why?
|
MicroRNAs | 3 | 2018 | 3790 | 0.040 |
Why?
|
RNA, Small Untranslated | 1 | 2018 | 77 | 0.040 |
Why?
|
Stereotaxic Techniques | 1 | 2020 | 549 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7408 | 0.040 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2017 | 67 | 0.040 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2018 | 238 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22023 | 0.030 |
Why?
|
Swimming | 1 | 2017 | 207 | 0.030 |
Why?
|
Homozygote | 1 | 2021 | 1788 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2020 | 1544 | 0.030 |
Why?
|
Bicycling | 1 | 2017 | 176 | 0.030 |
Why?
|
Ergolines | 1 | 2015 | 57 | 0.030 |
Why?
|
Lethargy | 1 | 2015 | 43 | 0.030 |
Why?
|
rab GTP-Binding Proteins | 1 | 2017 | 251 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2020 | 789 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2018 | 940 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2023 | 9185 | 0.030 |
Why?
|
Agriculture | 1 | 2016 | 190 | 0.030 |
Why?
|
Cholesterol | 1 | 2024 | 2924 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 616 | 0.030 |
Why?
|
Comorbidity | 2 | 2020 | 10551 | 0.030 |
Why?
|
Cell Communication | 1 | 2021 | 1653 | 0.030 |
Why?
|
Prognosis | 3 | 2020 | 29658 | 0.030 |
Why?
|
Hyperpigmentation | 1 | 2015 | 117 | 0.030 |
Why?
|
China | 1 | 2020 | 2339 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2020 | 1313 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2023 | 2420 | 0.030 |
Why?
|
Dopamine Agonists | 1 | 2015 | 352 | 0.030 |
Why?
|
Myocarditis | 1 | 2020 | 766 | 0.030 |
Why?
|
Syncope | 1 | 2015 | 428 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2020 | 2192 | 0.030 |
Why?
|
Calcium-Binding Proteins | 1 | 2017 | 1067 | 0.030 |
Why?
|
Time Factors | 3 | 2020 | 40165 | 0.030 |
Why?
|
Rats | 2 | 2020 | 23711 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2020 | 2209 | 0.030 |
Why?
|
Drug Interactions | 1 | 2016 | 1428 | 0.020 |
Why?
|
Erectile Dysfunction | 1 | 2015 | 452 | 0.020 |
Why?
|
Fatty Acids | 1 | 2020 | 1804 | 0.020 |
Why?
|
Young Adult | 2 | 2018 | 58741 | 0.020 |
Why?
|
Nanotechnology | 1 | 2017 | 709 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2023 | 2803 | 0.020 |
Why?
|
Posture | 1 | 2015 | 953 | 0.020 |
Why?
|
Genetic Markers | 1 | 2017 | 2608 | 0.020 |
Why?
|
Family Health | 1 | 2016 | 1257 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2018 | 2435 | 0.020 |
Why?
|
Ventricular Remodeling | 1 | 2018 | 1261 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1628 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18137 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2005 | 0.020 |
Why?
|
Hypotension | 1 | 2015 | 883 | 0.020 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2015 | 867 | 0.020 |
Why?
|
Placenta | 1 | 2018 | 1702 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2020 | 8158 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2016 | 1131 | 0.020 |
Why?
|
Iron | 1 | 2016 | 1786 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9631 | 0.020 |
Why?
|
Hippocampus | 1 | 2020 | 3738 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4902 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2016 | 2061 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5870 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2017 | 3106 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2021 | 18957 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2021 | 10446 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3616 | 0.020 |
Why?
|
Rural Population | 1 | 2016 | 2268 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2018 | 3880 | 0.020 |
Why?
|
Contrast Media | 1 | 2018 | 5305 | 0.020 |
Why?
|
Patient Discharge | 1 | 2018 | 3476 | 0.010 |
Why?
|
Databases, Factual | 1 | 2020 | 8035 | 0.010 |
Why?
|
Health Status | 1 | 2017 | 4081 | 0.010 |
Why?
|
Stroke Volume | 1 | 2018 | 5523 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12808 | 0.010 |
Why?
|
Length of Stay | 1 | 2018 | 6479 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58995 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2016 | 2276 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11152 | 0.010 |
Why?
|
Cell Line | 1 | 2017 | 15620 | 0.010 |
Why?
|
Liver | 1 | 2018 | 7509 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2017 | 4925 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22053 | 0.010 |
Why?
|
Environmental Exposure | 1 | 2016 | 4412 | 0.010 |
Why?
|
Apoptosis | 1 | 2017 | 9501 | 0.010 |
Why?
|
United States | 2 | 2020 | 72461 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15840 | 0.010 |
Why?
|
Pregnancy | 1 | 2018 | 29749 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 80372 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 87810 | 0.010 |
Why?
|